Powder: -20°C for 3 years | In solvent: -80°C for 1 year
FKBP12 PROTAC dTAG-7 (dTAG-7) is a heterobifunctional compound that selectively degrades the BET bromodomain transcriptional co-activator BRD4 by connecting BET bromodomains to the E3 ubiquitin ligase CRBN. Additionally, it serves as a degrader of FKBP12F36V when FKBP12F36V is expressed in-frame with a targeted protein.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 35 days | $ 1,280.00 |
Description | FKBP12 PROTAC dTAG-7 (dTAG-7) is a heterobifunctional compound that selectively degrades the BET bromodomain transcriptional co-activator BRD4 by connecting BET bromodomains to the E3 ubiquitin ligase CRBN. Additionally, it serves as a degrader of FKBP12F36V when FKBP12F36V is expressed in-frame with a targeted protein. |
Synonyms | dTAG-7 |
Molecular Weight | 1210.32 |
Formula | C63H79N5O19 |
CAS No. | 2064175-32-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
FKBP12 PROTAC dTAG-7 2064175-32-0 Chromatin/Epigenetic Epigenetic Reader Domain FKBP12 PROTAC dTAG 7 FKBP12 PROTAC dTAG7 FKBP-12 PROTAC dTAG-7 dTAG-7 inhibitor inhibit